The mean versus the gene: will national healthcare systems ever adopt personalised medicine?

By John F P Bridges While outcomes for any given treatment differ significantly among patients, national healthcare systems continue to take a top down population perspective in reviewing not only epidemiologic data but to evaluating the effectiveness and cost-effectiveness of new medicines. This top down approach, coupled with a growing need for cost containment, has…

You need to know the global issues in health economics

By Robert Hand (robert.hand@rxcomms.com) As a health economist and outcomes researcher, you may work primarily within a single country. Naturally, you know the economic, regulatory, and management issues of that country. However, with globalisation, you need increasingly to be aware of the corresponding conditions around the world. Why? Individual countries or cooperative groups of countries…

What is the value of outcomes research?

By Kevin Frick (kevin.frick@rxcomms.com) It is ironic that we should have to answer the question: “what is the value of outcomes research?” when outcomes research is a key component of establishing the value of healthcare. Despite the seemingly obvious answer, i.e. “we could not possibly establish the value of healthcare without outcomes research”, there is…